Last Week's GER IPO Research: Tencent Music, Softbank, Weimob, Luzhou, Junshi, Yancoal and Asiainfo
We had another busy week for IPO research the GER team. This week, we recommend participating in the Tencent Music Entertainment (TME US) IPO,...
502 Views
Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)
Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...
656 Views
Last Week in GER IPO Research: Wuxi, Mobvista, Yancoal, IDreamSky, Mogu, Asiainfo, Softbank & More!
Last week was a busy week for IPO content. In this edition, we highlight a differentiated AH premium piece on pharma outsourcer WuXi AppTec Co....
406 Views
Junshi Biosciences IPO Preview: A Sense of Déjà Vu Without the Excitement
Shanghai Junshi Bioscience Co. Ltd. (1387344D CH) is a biopharmaceutical company which is developing a pipeline of 13 biologic drugs, including...
420 Views
EM Health Care: Late Cycle Rotation
Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...
341 Views